Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01147497 · ClinicalTrials.gov registry record · NA
Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT01147497 is a NA study that has completed, run by Emory University. The registered enrollment target is 78 participants.
The verdict
NCT01147497, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
Because of misoprostol's known ability to cause cervical dilation, some family planning providers give their patients a dose of this drug prior to insertion. The goal of this study is to evaluate whether misoprostol prior to IUD insertion in nulliparous women eases insertion and decreases pain.
Interventions
- DRUG Placebo
- DRUG Misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01147497
The ClinicalTrials.gov registry entry for NCT01147497 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01147497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01147497 about?
NCT01147497 is a clinical study titled "Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women". Because of misoprostol's known ability to cause cervical dilation, some family planning providers give their patients a dose of this drug prior to insertion. The goal of this study is to evaluate whether misoprostol prior to IUD insertion in nulliparous women eases insertion and decreases pain.
What is the current status of trial NCT01147497?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2010-06. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01147497?
The interventions under investigation include: Placebo (DRUG), Misoprostol (DRUG).
Who is sponsoring clinical trial NCT01147497?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.